エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 3,660 | 3,695 | 3,530 | 3,530 | -125 | -3.4% | 23,300 |
2021/03/22 | 3,665 | 3,710 | 3,610 | 3,655 | -55 | -1.5% | 23,700 |
2021/03/19 | 3,540 | 3,710 | 3,530 | 3,710 | +85 | +2.3% | 32,300 |
2021/03/18 | 3,675 | 3,740 | 3,550 | 3,625 | -30 | -0.8% | 27,800 |
2021/03/17 | 3,665 | 3,825 | 3,650 | 3,655 | -10 | -0.3% | 50,900 |
2021/03/16 | 3,525 | 3,695 | 3,525 | 3,665 | +140 | +4% | 45,700 |
2021/03/15 | 3,550 | 3,610 | 3,480 | 3,525 | ±0 | ±0% | 20,100 |
2021/03/12 | 3,500 | 3,550 | 3,450 | 3,525 | +50 | +1.4% | 28,400 |
2021/03/11 | 3,395 | 3,480 | 3,360 | 3,475 | +80 | +2.4% | 23,400 |
2021/03/10 | 3,450 | 3,585 | 3,395 | 3,395 | +60 | +1.8% | 47,500 |
2021/03/09 | 3,210 | 3,370 | 3,175 | 3,335 | +90 | +2.8% | 51,200 |
2021/03/08 | 3,405 | 3,450 | 3,245 | 3,245 | -145 | -4.3% | 54,200 |
2021/03/05 | 3,385 | 3,400 | 3,205 | 3,390 | +5 | +0.1% | 67,000 |
2021/03/04 | 3,385 | 3,410 | 3,320 | 3,385 | -80 | -2.3% | 41,700 |
2021/03/03 | 3,570 | 3,580 | 3,450 | 3,465 | -95 | -2.7% | 37,600 |
2021/03/02 | 3,705 | 3,755 | 3,525 | 3,560 | -110 | -3% | 53,400 |
2021/03/01 | 3,555 | 3,685 | 3,485 | 3,670 | +230 | +6.7% | 73,600 |
2021/02/26 | 3,385 | 3,540 | 3,360 | 3,440 | -50 | -1.4% | 60,200 |
2021/02/25 | 3,525 | 3,585 | 3,470 | 3,490 | +70 | +2% | 36,600 |
2021/02/24 | 3,600 | 3,600 | 3,420 | 3,420 | -195 | -5.4% | 70,400 |
2021/02/22 | 3,705 | 3,740 | 3,615 | 3,615 | -40 | -1.1% | 38,000 |
2021/02/19 | 3,700 | 3,730 | 3,575 | 3,655 | -110 | -2.9% | 75,700 |
2021/02/18 | 3,830 | 3,895 | 3,765 | 3,765 | -90 | -2.3% | 45,600 |
2021/02/17 | 4,000 | 4,035 | 3,840 | 3,855 | -150 | -3.7% | 51,500 |
2021/02/16 | 3,900 | 4,130 | 3,880 | 4,005 | +75 | +1.9% | 74,000 |
2021/02/15 | 4,030 | 4,070 | 3,830 | 3,930 | -50 | -1.3% | 88,000 |
2021/02/12 | 4,225 | 4,300 | 3,890 | 3,980 | -210 | -5% | 200,300 |
2021/02/10 | 4,200 | 4,210 | 4,140 | 4,190 | -15 | -0.4% | 27,800 |
2021/02/09 | 4,180 | 4,290 | 4,165 | 4,205 | +35 | +0.8% | 43,200 |
2021/02/08 | 4,215 | 4,250 | 4,160 | 4,170 | -30 | -0.7% | 29,500 |
2021/02/05 | 4,290 | 4,330 | 4,180 | 4,200 | -80 | -1.9% | 39,200 |
2021/02/04 | 4,275 | 4,365 | 4,130 | 4,280 | +35 | +0.8% | 77,200 |
2021/02/03 | 4,210 | 4,270 | 4,120 | 4,245 | +105 | +2.5% | 79,900 |
2021/02/02 | 3,925 | 4,195 | 3,925 | 4,140 | +230 | +5.9% | 85,600 |
2021/02/01 | 3,835 | 3,960 | 3,770 | 3,910 | +40 | +1% | 49,000 |
2021/01/29 | 4,060 | 4,135 | 3,840 | 3,870 | -185 | -4.6% | 82,500 |
2021/01/28 | 3,895 | 4,075 | 3,850 | 4,055 | +80 | +2% | 54,600 |
2021/01/27 | 3,980 | 4,100 | 3,965 | 3,975 | +55 | +1.4% | 52,800 |
2021/01/26 | 4,090 | 4,110 | 3,920 | 3,920 | -195 | -4.7% | 52,100 |
2021/01/25 | 4,090 | 4,165 | 4,050 | 4,115 | +105 | +2.6% | 60,100 |
2021/01/22 | 4,010 | 4,065 | 3,925 | 4,010 | -30 | -0.7% | 58,100 |
2021/01/21 | 3,895 | 4,060 | 3,895 | 4,040 | +145 | +3.7% | 77,900 |
2021/01/20 | 3,850 | 3,900 | 3,830 | 3,895 | +45 | +1.2% | 34,400 |
2021/01/19 | 3,765 | 3,880 | 3,750 | 3,850 | +80 | +2.1% | 54,200 |
2021/01/18 | 3,665 | 3,785 | 3,630 | 3,770 | +120 | +3.3% | 48,000 |
2021/01/15 | 3,690 | 3,705 | 3,535 | 3,650 | -80 | -2.1% | 124,300 |
2021/01/14 | 3,820 | 3,900 | 3,685 | 3,730 | -135 | -3.5% | 71,200 |
2021/01/13 | 3,710 | 3,920 | 3,710 | 3,865 | +155 | +4.2% | 104,900 |
2021/01/12 | 3,950 | 3,960 | 3,710 | 3,710 | -240 | -6.1% | 140,200 |
2021/01/08 | 4,150 | 4,230 | 3,940 | 3,950 | -185 | -4.5% | 132,800 |
901~
950
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム